CLINICAL_TRIALS
trial_result
· 2020-03-31
Clinical Trial Update: Erbitux MEtastatic Colorectal Cancer Strategy Study [Phase 3]
Summary
Phase 3 trial update for Erbitux in metastatic colorectal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Armando Orlandi | Conditions: Antineoplastic Agents | Phase 3 | Status: COMPLETED